Biotechnology Company
Issues relating to the Biologics Price Competition and Innovation Act, Risk Evaluation Mitigation Strategies, industry user fees, S.934 - FDA Reauthorization Act of 2017, H.R. 2430-FDA Reauthorization Act of 2017
HCR - Health Issues
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FIERCE GOVERNMENT RELATIONS
1155 F Street NW, Suite 950, Washington, DC, 20004, US
WILLIAM KIRK BLALOCK MICHAEL CHAPPELL KIRSTEN CHADWICK ALEIX JARVIS KATE HULL WILLIAM PIPER DANIELLE MAURER TYLER STEPHENS ERIC ZULKOSKY (Director of Member Services, Majority Whip Steve Scalise, LD, Rep. Scalise, LA, Rep. Scalise, LA, Sen. Johanns, LC, Sen. Johanns, LC Sen. Dole, Mail Manager, Sen. Dole, Staff Assistant, Sen. Dole)
Director of Member Services, Majority Whip Steve Scalise, LD, Rep. Scalise, LA, Rep. Scalise, LA, Sen. Johanns, LC, Sen. Johanns, LC Sen. Dole, Mail Manager, Sen. Dole, Staff Assistant, Sen. Dole